The efficacy of chloroquine (25 mg base/kg over 3 days) in Plasmodium vivax malaria was
evaluated in 1995/96 in 342 patients living in an endemic area on the western border of …

The standard adult treatment regimen for Plasmodium vivax malaria is chloroquine (1500
mg over 3 d) plus primaquine (15 or 30 mg daily for 14 d), but patient compliance tends to be …

Abstract Thai adult males (N= 85) with acute Plasmodium vivax malaria and normal glucose-
6-phosphate dehydrogenase screening were randomized to receive 30 mg or 60 mg …

A retrospective analysis of all patients with Plasmodium vivax malaria who attended the
Hospital for Tropical Diseases in London, UK, between January 1994 and June 1995, was …

Following a recent, abrupt local increase in the incidence of vivax malaria, a study was
conducted in order to evaluate the efficacy of chloroquine for the treatment of 26 adult …

To define the current efficacy of Fansidar (F. Hoffmann-La Roche Ltd., Basel Switzerland)(
pyrimethamine and sulfadoxine), primaquine in a high dose, and artesunate for treating …

Chloroquine-resistant Plasmodium vivax has been reported in some Asian countries. In
2003, 161 patients infected with vivax malaria were treated according to the Thai National …

Primaquine is the only drag available that can eliminate hypnoxoites from the liver and
prevent relapses of vivax malaria. The World Health Organization recommends a course of …

Chloroquine has been the standard treatment for Plasmodium vivax malaria for more than
40 years in most regions of the world. Recently, however, chloroquine-resistant P. vivax has …

Relapse of Plasmodium vivax malaria following standard primaquine dosing has been
reported from many areas, and more recently from sub-Saharan Africa. In this report we …